Morgan Stanley lowered the firm’s price target on CSX (CSX) to $28 from $29 and keeps an Equal Weight rating on the shares. Q4 was “a modest miss,” but the focus will be on the 2025 guidance given the $350M of net headwinds mgmt. is expecting next year, the analyst tells investors. Some of the actions that will likely drive a year-over-year EBIT decline will pay long-term dividends, but consensus needs to come down through 2027 first, the analyst argues.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio